Texas A&M report links ractopamine exposure to canine heart injury: full analysis

A new Texas A&M case report is drawing attention to a livestock feed additive that many small-animal clinicians may not immediately consider when a dog arrives with tremors and dangerous arrhythmias. Researchers at the Texas A&M College of Veterinary Medicine & Biomedical Sciences reported that accidental ingestion of ractopamine was associated with severe cardiac injury in two dogs treated at the university’s Small Animal Teaching Hospital, with one recovering and the other dying after delayed care. The paper was published in Veterinary Record Case Reports and, according to the authors, is the first published report of natural ractopamine exposure in dogs. (vetmed.tamu.edu)

Ractopamine is a beta-agonist feed additive used in food-animal production to promote lean muscle growth. The Texas A&M authors note that the FDA approved ractopamine hydrochloride in 1999 for finishing pigs, in 2003 for beef cattle in confinement for slaughter, and in 2008 for finishing turkeys. While the compound has long been controversial in food-animal and trade policy discussions, the veterinary literature has contained little on accidental exposure in companion animals, even though dogs on farms or rural properties may have access to medicated feed or storage areas. (researchgate.net)

In the two Texas A&M cases, both dogs came from farm settings and presented with muscle tremors, ventricular arrhythmias, hypokalemia, and severe elevations in cardiac troponin I, consistent with myocardial injury. The major difference was timing. In the first case, the pet parents recognized the ingestion quickly and induced vomiting before hospital care; that dog was hospitalized, monitored, and ultimately recovered without long-term effects. In the second, the dog was found after an unknown period of exposure and arrived in critical condition, later dying despite intensive treatment. The authors concluded that early decontamination likely helped explain the different outcomes. (vetmed.tamu.edu)

The clinical takeaway may be as important as the toxicology signal itself. Texas A&M’s team said lidocaine, a common first choice for ventricular arrhythmias, was not effective in these patients. Once clinicians considered ractopamine’s adrenergic mechanism, beta blockers made more sense and were more successful, according to the report and the university’s press release. That gives emergency and critical care teams a more specific management clue when they’re dealing with suspected feed-additive exposure rather than a more routine arrhythmia case. (vetmed.tamu.edu)

There is also some historical context for concern. Earlier experimental and pathology literature linked ractopamine exposure in dogs, particularly greyhounds, to myocardial and vascular injury, including persistent conduction abnormalities and arterial lesions after dosing. What is new here is the real-world exposure scenario: not an experimental model, but naturally exposed dogs in an agricultural environment. That makes the report more relevant to general practitioners, ER teams, and toxicology consults that may see unexplained cardiovascular signs in dogs from farms, feedlots, or mixed-species households. (journals.sagepub.com)

Why it matters: For veterinary professionals, this report broadens the differential diagnosis for canine toxicosis and acute cardiac injury. In rural practice, it’s a reminder to ask specifically about access to medicated livestock feed, premixes, and storage bins when dogs present with tremors, ventricular tachycardia, or elevated troponin. It also reinforces the value of rapid decontamination, cardiac monitoring, electrolyte assessment, and early toxicology support. More broadly, the cases highlight how products labeled and regulated for food-animal use can still create companion-animal risk at the farm level, where species often co-mingle and pet parents may not realize a feed additive is dangerous to dogs. FDA feed labeling for ractopamine products includes animal safety warnings for the target species and reporting pathways for adverse events, but these canine cases suggest awareness on the companion-animal side may still lag. (researchgate.net)

What to watch: The next step is whether this case report changes frontline practice, including poison-center triage, CE content, and referral-hospital protocols for suspected ractopamine exposure. It will also be worth watching for additional published case reports or retrospective data that clarify dose-response patterns, optimal antiarrhythmic choices, and whether some dogs are at higher risk for severe myocardial injury than others. (vetmed.tamu.edu)